If you need more lookups,
subscriptions start at $34 USD/month.
Ivan Horak Location
West Orange, NJ, US
Ivan Horak Work
President for Research and Development, Chief Scientific Officer @ (February 2010 - Present)
CSO @ (January 2005 - Present)
President for Research and Development, Chief Scientitifc Officer @ Enzon Pharmaceuticals (February 2010 - Present)
CSO @ Enzon Pharmaceuticals, Inc. (January 2005 - Present)
CSO @ Immunomedics, Inc. (January 2002 - January 2005)
VP Clinical @ Pharmacia (January 1999 - January 2002)
VP Clinical Oncology @ Pharmacia (January 1999 - January 2002)
VP Clinical Oncology Global @ Pfizer (formerly Pharmacia) (January 1999 - January 2002)
Director @ Johnson & Johnson Pharamceutical Research and Development (JJPRD) (January 1995 - January 1999)
Ivan Horak Education
Univerzita Komenského v Bratislave
MD
1969-1975
Ivan Horak Skills
Business Strategy
Management
Sales
Customer Service
Clinical Trials
Translational Medicine
CRO
Cell Biology
ELISA
Infectious Diseases
Commercialization
Assay Development
Biotechnology
Cell
Regulatory Affairs
Immunology
Life Sciences
Cell Culture
Drug Discovery
Molecular Biology
Lifesciences
Oncology
Drug Development
GCP
Clinical Development
u.s. Food and Drug Administration Fda
Phase Iii
Cancer
Vaccines
Pharmacology
Regulatory Submissions
Microbiology
Pharmaceutical Industry
Biochemistry
Technology Transfer
From Ind to Nda
Biomarkers
R&d
FDA
Protein Chemistry
Biopharmaceuticals
Ivan Horak Summary
Ivan Horak, based in West Orange, NJ, US, is currently a President for Research and Development, Chief Scientific Officer at Enzon. Ivan Horak brings experience from previous roles at Enzon, Enzon Pharmaceuticals, Enzon Pharmaceuticals, Inc. and Immunomedics, Inc.. Ivan Horak holds a 1969 - 1975 MD @ Univerzita Komenského v Bratislave. With a robust skill set that includes Business Strategy, Management, Sales, Customer Service, Clinical Trials and more. Ivan Horak has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Ivan Horak?
Find contact details for 700 million professionals.